Parnassus Investments LLC Has $373.19 Million Holdings in Procter & Gamble Company (The) $PG

Parnassus Investments LLC cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 17.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,604,052 shares of the company’s stock after selling 565,367 shares during the period. Parnassus Investments LLC owned approximately 0.11% of Procter & Gamble worth $373,187,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in PG. Trilogy Capital Inc. boosted its stake in shares of Procter & Gamble by 1.1% in the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock worth $901,000 after buying an additional 67 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in shares of Procter & Gamble by 1.8% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock worth $549,000 after buying an additional 67 shares during the last quarter. Lorne Steinberg Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 2.7% in the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock worth $376,000 after buying an additional 68 shares during the last quarter. Grant Street Asset Management Inc. boosted its stake in shares of Procter & Gamble by 2.7% in the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock worth $376,000 after buying an additional 69 shares during the last quarter. Finally, Beech Hill Advisors Inc. lifted its stake in Procter & Gamble by 0.5% in the fourth quarter. Beech Hill Advisors Inc. now owns 14,238 shares of the company’s stock valued at $2,040,000 after purchasing an additional 70 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a report on Friday, March 27th. Jefferies Financial Group reduced their price objective on Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a report on Monday, April 20th. Wells Fargo & Company increased their price objective on Procter & Gamble from $158.00 to $164.00 and gave the company an “overweight” rating in a report on Monday, April 27th. Morgan Stanley reduced their price objective on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, Royal Bank Of Canada reduced their price objective on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a report on Thursday, April 9th. Eleven equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $160.78.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Commentary from investors and media continues to describe PG as a durable, dividend-oriented consumer staples name with steady cash flow, reinforcing the stock’s appeal as a defensive holding. Is The Procter & Gamble Company (PG) A Good Stock To Buy Now?
• Positive Sentiment: Jim Cramer highlighted P&G as one of the kinds of stocks that can help investors “safely own the techs,” reinforcing its role as a stable portfolio anchor during market volatility. Jim Cramer Says “The P&Gs and the J&Js in Your Portfolio Allow You to Safely Own the Techs”
• Positive Sentiment: P&G and OLAY announced virtual companion technology for skincare simulations, showing continued innovation in higher-engagement beauty and personal care products. Haut.AI Collaborates with OLAY on Virtual Companion Technology to Power Clinically Modeled Skincare Simulations
• Positive Sentiment: Brokerage coverage cited in a recent note showed PG still carrying an average “Moderate Buy” rating, which supports sentiment around the shares. Procter & Gamble Company (The) (NYSE:PG) Given Average Rating of “Moderate Buy” by Brokerages
• Neutral Sentiment: P&G and the American Academy of Family Physicians released an oral-health survey for Crest and Oral-B, mainly serving as a brand-marketing update rather than a clear earnings catalyst. New Survey from P&G and American Academy of Family Physicians Reveals 76% of Americans Say They Care About Their Oral Health, But When Polled, Only 3% of Americans Associate Oral Health with Whole Body Health
• Neutral Sentiment: PG also presented at the Evercore Consumer & Retail Conference, but the transcript headline alone does not indicate a major new financial surprise. The Procter and Gamble Company (PG) Presents at The 6th Annual Evercore Consumer and Retail Conference Transcript
• Negative Sentiment: Investors are also weighing restructuring news, including a leadership reshuffle and plans to cut more than 3,500 jobs globally, which could raise execution and transition concerns in the near term. Procter And Gamble Restructuring And Leadership Shift Create Valuation Watchpoints

Procter & Gamble Trading Down 0.4%

NYSE:PG opened at $148.50 on Friday. The company has a market cap of $345.80 billion, a P/E ratio of 21.71, a P/E/G ratio of 6.48 and a beta of 0.39. The stock’s fifty day moving average price is $144.53 and its two-hundred day moving average price is $147.69. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.03. The firm had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.54 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were given a dividend of $1.0885 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, April 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.60%.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.